Abstract
Aim. To study metabolic-hormonal status and psychological characteristics of young obese men. Material and methods. The study included 87 young obese men (BMI ≥30 kg/m2) aged 16-25 yr given medication or non-medication treatment for 12 weeks. Blood glucagon-like peptide-1 (GLP-1), insulin, and glucose levels were measured after orlistat intake. Final screening included biochemical and hormonal studies. 48 patients underwent psychological testing. Results. Orlistat therapy resulted in clinically significant reduction of body mass (by more than 5% in 50% of the patients). Cortisol level also decreased while testosterone level increased. Meal test revealed elevated baseline GLP-1 level in 77,7% of the patients. There was correlation between baseline GLP-1 and insulin levels (r=0,61; р=0,001). Orlistat therapy decreased anxiety and depression (p<0,05) as well as manifestations of external eating behaviour but increased those of restrictive eating behaviour.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
